Literature DB >> 31948652

Atrial Failure as a Clinical Entity: JACC Review Topic of the Week.

Felipe Bisbal1, Adrian Baranchuk2, Eugene Braunwald3, Antoni Bayés de Luna4, Antoni Bayés-Genís5.   

Abstract

Atrial dysfunction has been widely considered a marker or consequence of other cardiac conditions rather than the cause itself. Here, we propose the term atrial failure as a clinically relevant entity, defined as any atrial dysfunction causing impaired heart performance, symptoms, and worsening quality of life or life expectancy. Aspects of the etiology, mechanisms, and consequences of atrial failure are discussed. Recent advances in cardiac electrophysiology and imaging have improved our understanding of the highly complex atrial anatomy and function, underlying the paramount importance of the atria in optimal heart performance. It is time to reappraise the concept of the failing atrium as a primary cause or aggravating factor of the symptoms in many of our patients. The concept of atrial failure may foster basic and translational research to gain a better understanding of how to identify and manage atrial dysfunction.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial failure; atrial fibrillation; atrial function; heart failure; interatrial block; stroke

Year:  2020        PMID: 31948652     DOI: 10.1016/j.jacc.2019.11.013

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  33 in total

Review 1.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Cardiac Imaging for the Assessment of Left Atrial Mechanics Across Heart Failure Stages.

Authors:  Francesco Bandera; Anita Mollo; Matteo Frigelli; Giulia Guglielmi; Nicoletta Ventrella; Maria Concetta Pastore; Matteo Cameli; Marco Guazzi
Journal:  Front Cardiovasc Med       Date:  2022-01-13

3.  Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation.

Authors:  Liuying Zheng; Jin Wang; Rui Zhang; Yingyi Zhang; Jie Geng; Lu Cao; Xiaoyun Zhao; Jianhui Geng; Xinping Du; Yuecheng Hu; Hongliang Cong
Journal:  Comput Math Methods Med       Date:  2022-06-17       Impact factor: 2.809

Review 4.  Left Atrial Cardiomyopathy - A Challenging Diagnosis.

Authors:  Fabienne Kreimer; Michael Gotzmann
Journal:  Front Cardiovasc Med       Date:  2022-06-30

5.  Deep terminal negativity of the P-wave in V1 and stroke risk: The National Health and Nutrition Examination survey III.

Authors:  Youmei Shen; Mingfang Li; Minglong Chen
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-05-21       Impact factor: 1.485

6.  Low-Voltage Area at the Anterior Wall of the Left Atrium Is Associated With Thromboembolism in Atrial Fibrillation Patients With a Low CHA2DS2-VA Score.

Authors:  Xiangwei Ding; Mingfang Li; Hongwu Chen; Gang Yang; Fengxiang Zhang; Weizhu Ju; Kai Gu; Jianqing Li; Minglong Chen
Journal:  Front Cardiovasc Med       Date:  2022-06-13

Review 7.  The effects of cardiac stretch on atrial fibroblasts: analysis of the evidence and potential role in atrial fibrillation.

Authors:  Xixiao Li; Anna Garcia-Elias; Begoña Benito; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

Review 8.  Atrial fibrillation and stroke: importance of left atrium as assessed by echocardiography.

Authors:  Yoshinobu Suwa; Yoko Miyasaka; Naoki Taniguchi; Shoko Harada; Eri Nakai; Ichiro Shiojima
Journal:  J Echocardiogr       Date:  2022-01-23

9.  Peptidylglycine α-amidating monooxygenase is required for atrial secretory granule formation.

Authors:  Nils Bäck; Raj Luxmi; Kathryn G Powers; Richard E Mains; Betty A Eipper
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-13       Impact factor: 11.205

10.  Left Atrioventricular Coupling Index as a Prognostic Marker of Cardiovascular Events: The MESA Study.

Authors:  Theo Pezel; Bharath Ambale Venkatesh; Henrique Doria De Vasconcellos; Yoko Kato; Mahsima Shabani; Eric Xie; Susan R Heckbert; Wendy S Post; Steven J Shea; Norrina B Allen; Karol E Watson; Colin O Wu; David A Bluemke; João A C Lima
Journal:  Hypertension       Date:  2021-07-06       Impact factor: 9.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.